Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA.

PubWeight™: 3.55‹?› | Rank: Top 1%

🔗 View Article (PMID 1360090)

Published in Lancet on December 05, 1992

Authors

W Reardon1, R J Ross, M G Sweeney, L M Luxon, M E Pembrey, A E Harding, R C Trembath

Author Affiliations

1: Mothercare Unit of Clinical Genetics and Fetal Medicine, Institute of Child Health, London, UK.

Articles citing this

Mitochondrial DNA mutations and pathogenesis. J Bioenerg Biomembr (1997) 2.54

Prevalence of mitochondrial gene mutations among hearing impaired patients. J Med Genet (2000) 1.71

The development of mitochondrial medicine. Proc Natl Acad Sci U S A (1994) 1.68

Increased expression of mitochondrial-encoded genes in skeletal muscle of humans with diabetes mellitus. J Clin Invest (1995) 1.53

PED/PEA-15 gene controls glucose transport and is overexpressed in type 2 diabetes mellitus. EMBO J (1998) 1.47

Mitochondria. J Neurol Neurosurg Psychiatry (2003) 1.36

Mitochondrial polymorphisms and susceptibility to type 2 diabetes-related traits in Finns. Hum Genet (2005) 1.18

The genetics of inherited macular dystrophies. J Med Genet (2003) 1.14

Clinical mitochondrial genetics. J Med Genet (1999) 1.08

Characterization of mammalian translocase of inner mitochondrial membrane (Tim44) isolated from diabetic newborn mouse kidney. Proc Natl Acad Sci U S A (1998) 1.06

Mitochondria and diabetes mellitus: untangling a conflictive relationship? J Inherit Metab Dis (2009) 1.06

Activating HSP72 in rodent skeletal muscle increases mitochondrial number and oxidative capacity and decreases insulin resistance. Diabetes (2014) 1.06

Diabetes mellitus: The epidemic of the century. World J Diabetes (2015) 1.06

Absence of a reductase, NCB5OR, causes insulin-deficient diabetes. Proc Natl Acad Sci U S A (2004) 1.03

Genotype to phenotype correlations in mitochondrial encephalomyopathies associated with the A3243G mutation of mitochondrial DNA. J Neurol (1995) 1.00

The mitochondrial A10398G polymorphism, interaction with alcohol consumption, and breast cancer risk. PLoS One (2009) 0.97

Point mutation of the mitochondrial tRNA(Leu) gene (A 3243 G) in maternally inherited hypertrophic cardiomyopathy, diabetes mellitus, renal failure, and sensorineural deafness. J Med Genet (1995) 0.95

Congenital encephalomyopathy and adult-onset myopathy and diabetes mellitus: different phenotypic associations of a new heteroplasmic mtDNA tRNA glutamic acid mutation. Am J Hum Genet (1995) 0.93

The genetics of strabismus. J Med Genet (2004) 0.92

A novel class of tests for the detection of mitochondrial DNA-mutation involvement in diseases. Am J Hum Genet (2003) 0.91

Mitochondrial dysfunction has divergent, cell type-dependent effects on insulin action. Mol Metab (2014) 0.90

Mitochondrial disorders and the kidney. Arch Dis Child (1998) 0.90

Characterisation of the macular dystrophy in patients with the A3243G mitochondrial DNA point mutation with fundus autofluorescence. Br J Ophthalmol (2008) 0.90

Chaperoning to the metabolic party: The emerging therapeutic role of heat-shock proteins in obesity and type 2 diabetes. Mol Metab (2014) 0.88

Mitochondrial gene mutations and human diseases: a prolegomenon. Am J Hum Genet (1994) 0.87

Mitochondrial DNA variants in the pathogenesis of type 2 diabetes - relevance of asian population studies. Rev Diabet Stud (2009) 0.86

Lactate and risk of incident diabetes in a case-cohort of the atherosclerosis risk in communities (ARIC) study. PLoS One (2013) 0.85

Platelet mitochondrial DNA methylation: a potential new marker of cardiovascular disease. Clin Epigenetics (2015) 0.85

Endocrine disorders in mitochondrial disease. Mol Cell Endocrinol (2013) 0.83

Association of upregulated activity of K(ATP) channels with impaired insulin secretion in UCP1-expressing insulinoma cells. J Physiol (2002) 0.80

Plasma lactate and diabetes risk in 8045 participants of the atherosclerosis risk in communities study. Ann Epidemiol (2013) 0.77

Japanese case of diabetes mellitus and deafness with mutation in mitochondrial tRNA(Leu(UUR)) gene. Lancet (1993) 0.77

Phosphoprotein enriched in astrocytes (PEA)-15: a potential therapeutic target in multiple disease states. Pharmacol Ther (2014) 0.76

MELAS syndrome. West J Med (1995) 0.75

Reactive oxygen species stimulate mitochondrial allele segregation toward homoplasmy in human cells. Mol Biol Cell (2016) 0.75

Mitochondrial mutation commonly associated with Leber's hereditary optic neuropathy observed in a patient with Wolfram syndrome (DIDMOAD). J Med Genet (1994) 0.75

Cardiovascular disorders in patients with diabetes mellitus. Exp Clin Cardiol (2006) 0.75

Mitochondrial gene mutations and diabetes mellitus. Lancet (1993) 0.75

[Diagnostic approach of macular degeneration with "spectral-domain" OCT: clinical case]. Pan Afr Med J (2015) 0.75

Mitochondrial gene mutations and diabetes mellitus. Lancet (1993) 0.75

Rapid Detection of the mt3243A > G Mutation Using Urine Sediment in Elderly Chinese Type 2 Diabetic Patients. J Diabetes Res (2017) 0.75

Articles by these authors

Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature (1991) 9.89

Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature (1988) 7.65

Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. Nat Genet (2000) 7.20

Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features. Brain (1981) 5.19

A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet (1990) 4.96

The clinical features of hereditary motor and sensory neuropathy types I and II. Brain (1980) 4.79

Classification of the hereditary ataxias and paraplegias. Lancet (1983) 4.44

LMNA, encoding lamin A/C, is mutated in partial lipodystrophy. Nat Genet (2000) 3.73

Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet (1992) 3.30

Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation. Cell (1993) 3.28

Genetic heterogeneity and mitochondrial DNA heteroplasmy in Leber's hereditary optic neuropathy. J Med Genet (1989) 3.25

Hereditary "pure" spastic paraplegia: a clinical and genetic study of 22 families. J Neurol Neurosurg Psychiatry (1981) 2.95

The clinical features of mitochondrial myopathy. Brain (1986) 2.95

The clinical features of Leber's hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation. Brain (1995) 2.94

The clinical features and classification of the late onset autosomal dominant cerebellar ataxias. A study of 11 families, including descendants of the 'the Drew family of Walworth'. Brain (1982) 2.91

Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis. Neurology (2008) 2.87

Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome. Nat Genet (1994) 2.83

Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family. J Med Genet (2000) 2.82

Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-beta(1) and bone morphogenetic proteins. Circulation (2001) 2.66

The spectrum of Silver-Russell syndrome: a clinical and molecular genetic study and new diagnostic criteria. J Med Genet (1999) 2.63

Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation. Brain (1992) 2.62

BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension. Am J Hum Genet (2000) 2.51

Association of the INS VNTR with size at birth. ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. Nat Genet (1998) 2.49

Association between X-linked mixed deafness and mutations in the POU domain gene POU3F4. Science (1995) 2.38

A study of hereditary essential tremor. Brain (1994) 2.37

Genetic aspects of hereditary motor and sensory neuropathy (types I and II). J Med Genet (1980) 2.36

Mitochondrial encephalopathies: molecular genetic diagnosis from blood samples. Lancet (1991) 2.36

Localisation of a gene implicated in a severe speech and language disorder. Nat Genet (1998) 2.33

Uniparental paternal disomy in Angelman's syndrome. Lancet (1991) 2.26

Natural history of sickle cell anemia in Saudi Arabs. A study of 270 subjects. Ann Intern Med (1978) 2.24

A clinical and genetic study of campomelic dysplasia. J Med Genet (1995) 2.20

Meiotic stability and genotype-phenotype correlation of the trinucleotide repeat in X-linked spinal and bulbar muscular atrophy. Nat Genet (1992) 2.18

Pedigree analysis in Leber hereditary optic neuropathy families with a pathogenic mtDNA mutation. Am J Hum Genet (1995) 2.17

Evidence for glutamate excitotoxicity in Huntington's disease with proton magnetic resonance spectroscopy. Lancet (1994) 2.17

Effect of oral erythromycin on gallbladder motility in normal subjects and subjects with gallstones. Gastroenterology (1992) 2.13

Clinical and laboratory findings in referrals for mitochondrial DNA analysis. Arch Dis Child (1998) 2.12

Activating and inactivating mutations in the human GNAS1 gene. Hum Mutat (2000) 2.09

The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study. Neurology (2011) 2.06

Primary pathogenic mtDNA mutations in multigeneration pedigrees with Leber hereditary optic neuropathy. Am J Hum Genet (1996) 2.03

Absence of linkage of hereditary motor and sensory neuropathy type I to chromosome 1 markers. Genomics (1989) 2.00

Spinocerebellar degeneration associated with a selective defect of vitamin E absorption. N Engl J Med (1985) 1.99

Fetal haemoglobin production and the sickle gene in the oases of Eastern Saudi Arabia. Br J Haematol (1978) 1.98

Diagnosis of Gerstmann-Sträussler syndrome in familial dementia with prion protein gene analysis. Lancet (1989) 1.97

Reliable routine estimation of small amounts of foetal haemoglobin by alkali denaturation. J Clin Pathol (1972) 1.88

Mitochondrial myopathies: clinical and biochemical features of 30 patients with major deletions of muscle mitochondrial DNA. Ann Neurol (1989) 1.88

A premutation that generates a defect at crossing over explains the inheritance of fragile X mental retardation. Am J Med Genet (1985) 1.83

Thalassaemia in the British. Br Med J (1973) 1.82

Use of a chromosome 21 cloned DNA probe for the analysis of non-disjunction in Down syndrome. Hum Genet (1984) 1.81

Chronic subdural haematoma. Q J Med (1979) 1.81

Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia. J Med Genet (2003) 1.76

Neural basis of an inherited speech and language disorder. Proc Natl Acad Sci U S A (1998) 1.76

High-dose leptin activates human leukocytes via receptor expression on monocytes. J Immunol (2001) 1.74

Leber's hereditary optic neuropathy: the clinical relevance of different mitochondrial DNA mutations. J Med Genet (1995) 1.73

Association of atopic dermatitis to the beta subunit of the high affinity immunoglobulin E receptor. Br J Dermatol (1998) 1.69

A non-HLA gene within the MHC in psoriasis. Lancet (1999) 1.67

Neuroacanthocytosis. A clinical, haematological and pathological study of 19 cases. Brain (1991) 1.67

Hereditary demyelinating neuropathy of infancy. A genetically complex syndrome. Brain (1997) 1.65

The phenotypic manifestations of chromosome 17p11.2 duplication. Brain (1997) 1.63

Intrafamilial correlation in Friedreich's ataxia. Clin Genet (1981) 1.62

Degenerative cerebellar ataxia and focal dystonia. Mov Disord (1988) 1.58

Molecular analysis of the PDS gene in Pendred syndrome. Hum Mol Genet (1998) 1.58

Familial infiltrative fibromatosis (desmoid tumours) (MIM135290) caused by a recurrent 3' APC gene mutation. Hum Mol Genet (1996) 1.57

Spinocerebellar degeneration secondary to chronic intestinal malabsorption: a vitamin E deficiency syndrome. Ann Neurol (1982) 1.56

Community-based infant hearing screening for early detection of permanent hearing loss in Lagos, Nigeria: a cross-sectional study. Bull World Health Organ (2008) 1.55

Vitamin E and the nervous system. Crit Rev Neurobiol (1987) 1.55

Duplication of chromosome 15 in the region 15q11-13 in a patient with developmental delay and ataxia with similarities to Angelman syndrome. J Med Genet (1993) 1.54

Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. Brain (1995) 1.53

Radiological malformations of the ear in Pendred syndrome. Clin Radiol (1998) 1.52

F-cell production in sickle cell anemia: regulation by genes linked to beta-hemoglobin locus. Science (1981) 1.51

Pearson syndrome and mitochondrial encephalomyopathy in a patient with a deletion of mtDNA. Am J Hum Genet (1991) 1.50

Genetics of pulmonary hypertension: from bench to bedside. Eur Respir J (2002) 1.50

Kyphomelic dysplasia. J Med Genet (1989) 1.48

The mitochondrial DNA transfer RNA(Lys)A-->G(8344) mutation and the syndrome of myoclonic epilepsy with ragged red fibres (MERRF). Relationship of clinical phenotype to proportion of mutant mitochondrial DNA. Brain (1993) 1.48

Autosomal-dominant GTPCH1-deficient DRD: clinical characteristics and long-term outcome of 34 patients. J Neurol Neurosurg Psychiatry (2009) 1.46

Pendred syndrome--100 years of underascertainment? QJM (1997) 1.45

Psychiatric morbidity in patients with peripheral vestibular disorder: a clinical and neuro-otological study. J Neurol Neurosurg Psychiatry (1992) 1.45

Peroneal muscular atrophy with pyramidal features. J Neurol Neurosurg Psychiatry (1984) 1.45

A case-control study of idiopathic torsion dystonia. Mov Disord (1991) 1.45

Mapping of a novel locus for achromatopsia (ACHM4) to 1p and identification of a germline mutation in the alpha subunit of cone transducin (GNAT2). J Med Genet (2002) 1.44

Psoriasis is associated with pleiotropic susceptibility loci identified in type II diabetes and Crohn disease. J Med Genet (2007) 1.44

Angelman syndrome. J Med Genet (1992) 1.42

Hereditary distal spinal muscular atrophy. A report on 34 cases and a review of the literature. J Neurol Sci (1980) 1.41

Infant hearing screening: route to informed choice. Arch Dis Child (2004) 1.41

The relationship between serum prolactin and immunocytochemical staining for prolactin in patients with pituitary macroadenomas. Clin Endocrinol (Oxf) (1985) 1.40

The heart disease of Friedreich's ataxia: a clinical and electrocardiographic study of 115 patients, with an analysis of serial electrocardiographic changes in 30 cases. Q J Med (1983) 1.39

Serum vitamin E concentrations in degenerative ataxias. J Neurol Neurosurg Psychiatry (1989) 1.38

Prenatal diagnosis of mitochondrial DNA8993 T----G disease. Am J Hum Genet (1992) 1.38

Dopa-responsive dystonia in British patients: new mutations of the GTP-cyclohydrolase I gene and evidence for genetic heterogeneity. Hum Mol Genet (1996) 1.38

Recurrence risks and prognosis in severe sporadic osteogenesis imperfecta. J Med Genet (1987) 1.38

Maternal uniparental disomy 7 in Silver-Russell syndrome. J Med Genet (1997) 1.37

Autosomal recessive forms of hereditary motor and sensory neuropathy. J Neurol Neurosurg Psychiatry (1980) 1.36

The non-deletion type of alpha thalassaemia/mental retardation: a recognisable dysmorphic syndrome with X linked inheritance. J Med Genet (1991) 1.36

Pendred syndrome. J Med Genet (1996) 1.34

A single nucleotide polymorphism (SNP) in the leptin receptor is associated with BMI, fat mass and leptin levels in postmenopausal Caucasian women. Hum Genet (2001) 1.34